Methodological problems in the method used by IQWiG within early benefit assessment of new pharmaceuticals in Germany
Year of publication: |
2019
|
---|---|
Authors: | Herpers, Matthias ; Dintsios, Charalabos-Markos |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 20.2019, 1, p. 45-57
|
Subject: | IQWiG | Early benefit assessment | Benefit quantification | Dichotomization | Pivotal trials | Statistical validity | Deutschland | Germany | Arzneimittel | Pharmaceuticals | Kosten-Nutzen-Analyse | Cost-benefit analysis |
-
Münkler, Laura, (2015)
-
Blome, Christine, (2017)
-
Lebioda, Andrea, (2014)
- More ...
-
Some essential clarifications: IQWiG comments on two critiques of the efficiency frontier approach
Dintsios, Charalabos-Markos, (2010)
-
Ruof, Jörg, (2014)
-
Using the Analytic Hierarchy Process to Elicit Patient Preferences
Hummel, Marjan, (2012)
- More ...